Table 3.
MicroRNA ID | Mean expression controls | Mean expression BE | Mean expression EAC | Fold induction BE/controls | Fold induction EAC/controls | Fold induction EAC/BE |
---|---|---|---|---|---|---|
hsa-let-7d-3p | 1.02 | 0.78 | 0.85 | 0.76 (p = 0.011) | 0.83 | 1.09 |
hsa-let-7e-5p | 1.22 | 1.08 | 1.61 | 0.88 | 1.32 | 1.50 (p = 0.038) |
hsa-miRNA-1-3p | 1.74 | 0.61 | 0.51 | 0.35 | 0.29 | 0.84 |
hsa-miRNA-10a-5p | 1.01 | 0.64 | 0.57 | 0.63 | 0.56 (p = 0.018) | 0.89 |
hsa-miRNA-92b-3p | 1.13 | 0.88 | 0.72 | 0.77 | 0.64 | 0.82 |
hsa-miRNA-95-3p | 1.18 | 2.61 | 0.93 | 2.21 | 0.79 | 0.36 |
hsa-miRNA-122-5p | 1.09 | 1.65 | 1.07 | 1.52 | 0.99 | 0.65 |
hsa-miRNA-127-3p | 1.31 | 0.79 | 1.30 | 0.60 | 0.99 | 1.65 |
hsa-miRNA-133a-3p | 1.64 | 0.51 | 0.52 | 0.31 | 0.32 | 1.02 |
hsa-miRNA-133b | 2.21 | 0.71 | 0.70 | 0.32 | 0.32 | 0.99 |
hsa-miRNA-136-5p | 1.17 | 0.68 | 1.43 | 0.58 | 1.22 | 2.11 |
hsa-miRNA-154-5p | 1.31 | 0.84 | 1.32 | 0.64 | 1.01 | 1.58 |
hsa-miRNA-186-5p | 1.01 | 0.86 | 1.05 | 0.86 | 1.04 | 1.21 (p = 0.01) |
hsa-miRNA-194-5p | 1.12 | 2.47 | 2.55 | 2.21 | 2.28 | 1.03 |
hsa-miRNA-195-5p | 1.00 | 1.25 | 1.46 | 1.24 | 1.45 (p = 0.02) | 1.17 |
hsa-miRNA-365a-3p | 1.07 | 0.87 | 0.67 | 0.82 | 0.62 (p = 0.02) | 0.76 |
hsa-miRNA-382-5p | 1.15 | 0.76 | 1.57 | 0.65 | 1.36 | 2.08 (p = 0.007) |
hsa-miRNA-451a | 1.10 | 2.01 | 1.29 | 1.83 (p = 0.029) | 1.18 | 0.64 |
hsa-miRNA-500a-5p | 1.09 | 0.77 | 0.65 | 0.71 | 0.59 | 0.84 |
hsa-miRNA-532-3p | 1.03 | 0.96 | 0.74 | 0.93 | 0.71 | 0.77 (p = 0.038) |
hsa-miRNA-574-3p | 1.02 | 0.87 | 0.72 | 0.85 | 0.71 (p = 0.043) | 0.83 |
hsa-miRNA-1974 | 1.39 | 3.20 | 1.73 | 2.31 | 1.25 | 0.54 |
MicroRNAs significantly (p < 0.05) or more than 1.5-fold up- or down-regulated comparing plasma samples from esophageal adenocarcinoma (EAC), Barrett’s esophagus (BE), and controls. Mean expression along with their fold induction are shown